Latest Diabetes management Stories

Diabetes Support Supplements contains one gram of pure cinnamon to assist in healthy blood sugar levels and provide cardiovascular support Rancho Palos Verdes, CA (PRWEB) October 21, 2012 Diabetes Support contains pure cinnamon, and according to previous studies, cinnamon has a positive effect on fasting glucose levels for those with Type 2 Diabetes. In a study published in European Journal of Clinical Investigation, “The cinnamon extract seems to have a moderate effect in reducing...

MILPITAS, Calif., Oct. 16, 2012 /PRNewswire/ -- A new study suggests that blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in type 2 diabetes patients who do not take insulin. The study is published online in Diabetes Technology & Therapeutics and appeared in the publication's September print issue. The preliminary study findings were based on a retrospective analysis of health insurance data and was led by Dr. Naunihal Virdi,...

The primary objective of this 22 week study is to investigate the change in glycosylated hemoglobin (HbA1c) after receiving the new drug, as compared to those receiving a placebo. Birmingham, AL (PRWEB) October 15, 2012 In recent years, the number of patients with type 2 diabetes has continuously been increasing worldwide. According to the information published in 2009 by the International Diabetes Federation (IDF), the number of patients with diabetes was estimated to be 285 million...

BOSTON, Oct. 11, 2012 /PRNewswire/ -- Could bariatric surgery become the standard care for Type 2 diabetes in severely obese patients? Dr. Francesco Rubino, director of the Diabetes Surgery Center at New York-Presbyterian Hospital / Weill Cornell Medical Center, believes there is much evidence in favor of this idea, and he will discuss this evidence during his Cardiometabolic Health Congress keynote address from 2 p.m. to 2:45 p.m. on Thursday, Oct. 11, 2012, titled "Are We Ready for...

Strategies implemented in high-income countries to improve blood glucose control in people with type 1 diabetes and so reduce complications, such as heart attacks, strokes, and early death, are working, but there is much need for further improvement, according to a study from Scotland published in this week's PLOS Medicine. Using information from national databases representing over 20 000 patients from 2005 to 2008, Scottish researchers led by Helen Colhoun from the University of Dundee,...

Use of electronic health records was associated with improved drug-treatment intensification, monitoring, and risk-factor control among patients with diabetes, according to a new Kaiser Permanente study. In the study, which appears in the current issue of Annals of Internal Medicine, researchers also noted greater improvements among patients with poorer control of their diabetes and lipids. The findings provide an important contribution to the evidence base by demonstrating that, for the...

WESTPORT, Conn., Oct. 2, 2012 /PRNewswire/ -- dLife Healthcare Solutions has been selected to present its diabetes program used to engage and improve self-care for people with diabetes at the 2012 URAC Global Diabetes Management Mini Summit. dLife will share details of this approach along with recent results during a poster session on October 11, 2012 at the Parc 55 Wyndham Union Square Hotel, in San Francisco, CA. dLife will exhibit how to integrate a broad media-based...

BERLIN, Oct. 2, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced that use of the investigational medicine canagliflozin substantially lowered blood glucose levels when used as add-on therapy in patients on insulin therapy for type 2 diabetes and who are considered to be at greater risk for cardiovascular disease. These results were presented at the 48th European Association for the Study of Diabetes (EASD) Annual Meeting. CANVAS (CANagliflozin...

RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 2, 2012 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announce data from a pooled analysis of two phase IIb trials in adults with type 2 diabetes (T2D) for an investigational SGLT-2 inhibitor, empagliflozin, at the 48(th) European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin. The new analysis showed a reduction in systolic blood pressure with empagliflozin,...

OAKLAND, Calif., Oct. 1, 2012 /PRNewswire/ -- Use of electronic health records was associated with improved drug-treatment intensification, monitoring and risk-factor control among patients with diabetes, according to a new Kaiser Permanente study. In the study, which appears in the current issue of Annals of Internal Medicine, researchers also noted greater improvements among patients with poorer control of their diabetes and lipids. The findings provide an important contribution...